sunlenca
Generic: lenacapavir sodium
Labeler: gilead sciences, inc.Drug Facts
Product Profile
Brand Name
sunlenca
Generic Name
lenacapavir sodium
Labeler
gilead sciences, inc.
Dosage Form
TABLET, FILM COATED
Routes
Active Ingredients
lenacapavir sodium 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
61958-3001
Product ID
61958-3001_1181413a-1da0-463f-bd33-a2681d2fcd9b
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
NDA
Application Number
NDA215974
Listing Expiration
2027-12-31
Marketing Start
2022-12-22
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
619583001
Hyphenated Format
61958-3001
Supplemental Identifiers
RxCUI
UNII
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
sunlenca (source: ndc)
Generic Name
lenacapavir sodium (source: ndc)
Application Number
NDA215974 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 1 POUCH in 1 CARTON (61958-3001-1) / 1 BLISTER PACK in 1 POUCH / 4 TABLET, FILM COATED in 1 BLISTER PACK
- 1 POUCH in 1 CARTON (61958-3001-2) / 1 BLISTER PACK in 1 POUCH / 5 TABLET, FILM COATED in 1 BLISTER PACK
- 4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3001-3)
Packages (3)
61958-3001-1
1 POUCH in 1 CARTON (61958-3001-1) / 1 BLISTER PACK in 1 POUCH / 4 TABLET, FILM COATED in 1 BLISTER PACK
61958-3001-2
1 POUCH in 1 CARTON (61958-3001-2) / 1 BLISTER PACK in 1 POUCH / 5 TABLET, FILM COATED in 1 BLISTER PACK
61958-3001-3
4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3001-3)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "1181413a-1da0-463f-bd33-a2681d2fcd9b", "openfda": {"unii": ["BDT58WJ9WE"], "rxcui": ["2625890", "2625896", "2625897", "2625898", "2625899", "2625900", "2625904", "2625909", "2625911", "2625912"], "spl_set_id": ["e5652804-29c4-40d7-aeb2-0142ed2a7b5b"], "manufacturer_name": ["Gilead Sciences, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 POUCH in 1 CARTON (61958-3001-1) / 1 BLISTER PACK in 1 POUCH / 4 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "61958-3001-1", "marketing_start_date": "20221222"}, {"sample": false, "description": "1 POUCH in 1 CARTON (61958-3001-2) / 1 BLISTER PACK in 1 POUCH / 5 TABLET, FILM COATED in 1 BLISTER PACK", "package_ndc": "61958-3001-2", "marketing_start_date": "20221222"}, {"sample": false, "description": "4 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (61958-3001-3)", "package_ndc": "61958-3001-3", "marketing_start_date": "20241113"}], "brand_name": "Sunlenca", "product_id": "61958-3001_1181413a-1da0-463f-bd33-a2681d2fcd9b", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Breast Cancer Resistance Protein Inhibitors [MoA]", "Cytochrome P450 3A Inhibitors [MoA]", "HIV Capsid Inhibitors [MoA]", "Human Immunodeficiency Virus 1 Capsid Inhibitor [EPC]", "P-Glycoprotein Inhibitors [MoA]"], "product_ndc": "61958-3001", "generic_name": "LENACAPAVIR SODIUM", "labeler_name": "Gilead Sciences, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Sunlenca", "active_ingredients": [{"name": "LENACAPAVIR SODIUM", "strength": "300 mg/1"}], "application_number": "NDA215974", "marketing_category": "NDA", "marketing_start_date": "20221222", "listing_expiration_date": "20271231"}